Bristol Myers Squibb Network of Women (B-NOW San Diego) and #HBASanDiego are excited to have Tiffany Sepp as one of exceptional panelists in an in-person, moderated panel discussion on November 9th, 2023. We will hear her and other panelists' insights on career growth, overcoming challenges, and achieving success in work and life. This event will feature time for networking with light refreshments and drinks, and an audience Q & A with the panelists. Register: https://bit.ly/HBASD110923 #HBAimpact
Vanguard Clinical, Inc.
生物技术研究
San Diego，CA 2,372 位关注者
Contract Research Organization and Functional Service Provider offering "white glove service", transparency, & passion
关于我们
Healthcare is about people. That’s why at Vanguard Clinical we work to build the best possible relationships with our clients and the medical professionals we engage on their behalf. Motivated investigators achieve faster enrollment with fewer screen failures and protocol deviations, saving our clients both time and money. We look forward to building a long lasting relationship with your organization. With over 20 years of industry experience, Vanguard Clinical Inc. is a leader in clinical trial management. Our highly talented and diverse team of consultants has the expertise to carry out all phases of trials in many therapeutic areas. At Vanguard Clinical, we understand that the right patient population can be anywhere. With experience conducting trials on five continents, we recognize the challenges and logistics unique to certain areas of the world. From regulations to training, Vanguard Clinical employs the optimal strategy to ensure trials are conducted consistently and return the best possible data. A successful clinical trial can be a marathon, and Vanguard Clinical will be by your side the entire way. During startup, we can manage or assist with initial feasibility and budget forecasting, negotiating contracts with vendors and clinical sites, protocol writing, and Investigator on-boarding. As trials progress, we provide expert analysis to ensure resources are being utilized efficiently. We pride ourselves on quality results, integrity of data, and ongoing process development to ensure the success of the projects for our clients. We strive to be innovators and are always refining our processes to provide a tight feedback loop between the monitors in the field and our clients, keeping them continuously informed about the status of a trial.
- 网站
-
https://vanguardclinical.com
Vanguard Clinical, Inc.的外部链接
- 所属行业
- 生物技术研究
- 规模
- 51-200 人
- 总部
- San Diego，CA
- 类型
- 私人持股
- 创立
- 2012
- 领域
- Clinical Operations、Clinical Trial Management、Clinical Monitoring、Trial Master File Management、Clinical Development、Vendor Oversight、CRO Oversight和Functional Service Provider
地点
-
主要
获取路线
12265 El Camino Real
Suite 200
US，CA，San Diego，92130
Vanguard Clinical, Inc.员工
动态
-
Exciting News: A Dream Turned Reality! I am beyond excited to announce the official launch of Vanguard Clinical Rare Disease Foundation, a non-profit dedicated to accelerating the development and delivery of innovative therapies for ultra-rare pediatric patients. This foundation represents the culmination of a dream I've had since embarking on the Zebronkysen journey in 2023, and my relentless passion to make a difference in the lives of those who need it most. At VCRDF, our mission is clear: to reimagine the drug development process itself, making it faster, more efficient, and infinitely scalable. We believe the process is our product—where the methods used to create therapies are as transformative as the treatments themselves. By challenging conventional timelines, breaking through systemic barriers, and pushing the boundaries of what’s possible, we aim to deliver treatments at the speed of need. We embrace creative ideas, innovative science, and bold regulatory strategies to turn the impossible into reality. For families waiting for hope, we make hope happen—faster, smarter, and without limits. This is just the beginning. We invite you to join us in this journey as we forge new pathways, deliver life-changing therapies, and bring hope to those who need it most. Stay connected with us for upcoming initiatives and ways you can get involved and ways you can help me to get treatments to these precious children and their families. Thank you to all those who have cheered me on to this point, for believing in this mission and for being part of something truly transformative. Together, we will make a lasting impact. #VanguardClinicalRareDiseaseFoundation #raredisease #passionprojects #neverevergiveup
-
-
Don't miss the chance to connect with our CEO/Founder Tiffany Sepp in Boston next week! #genetherapy #raredisease
-
-
So proud of my ImmunoGen colleagues and friends and of course my Vanguard Clinical, Inc. clinical operations team for the role they each played in this! I am thankful for this drug and the hope it brings to give ovarian cancer patients more good days. ♥️ What a special chapter this was.
NEWS: Today, we’re presenting late-breaking data from the long-term analysis of the Phase 3 MIRASOL trial for certain women living with #OvarianCancer on our treatment. This data builds on our commitment to care for people living with difficult-to-treat cancers. Read more: https://bit.ly/3Rd29by [Image description: On-screen text reads, “Oncology News. Phase 3 MIRASOL Trial Final Data.”]
-
-
Seven years ago, we had our first fundraiser. Many of you were there that night. And many more have joined us since to create a group of supporters that are second to none. This amazing community came together again to raise…drum roll… $1.6M from our 7th Take A Swing Fore Batten online auction, our live and simulator tournaments! We broke another record, thanks to you! Karen, David, Amelia, and Makenzie celebrate and thank everyone. Because of you, Amelia and Makenzie received their 4th doses of Zebronkysen yesterday and are in good spirits heading into their birthday weekend. The foundation and the family are hard at work moving the science forward to help not just our girls but the CLN3 community. We could not do this alone. We thank you from the bottom of our hearts. #raredisease #battendisease #golfforgood
-
-
We are so proud of the work we are doing as a boldly different CRO, and thankful for the reminder in these beautiful smiles of why we do what we do. Cheers to Amelia and Makenzie!
Celebrating the completion of the 4th dose of Zebronkysen for these beautiful and brave warriors! 🦓 🐒 💕💜 I remain in complete awe and humility by what we've achieved together. Thank you Karen and David and the ForeBatten Foundation for your trust in all of us and letting us be a part of this truly incredible story and your sweet girls’ smiling faces! #battendisease #raredisease #nanorare #zebronkysen #projectbutterfly #wherethereisawillthereisaway
-
-
#RareDiseaseDay 🦓 ✨ At Vanguard Clinical, we stand with the rare disease community—championing research, advocating for progress, and supporting the development of life-changing treatments. 🔬We are committed to driving innovation in clinical research for rare diseases, providing the necessary support to accelerate breakthroughs, and bringing hope to patients and families. 💜 Today, we honor the resilience of those living with rare diseases and reaffirm our mission to boldly redefine clinical research to meet their needs. 📢 Join us in raising awareness—because every rare disease deserves attention, and every patient deserves options.
-
-
Incredibly disappointing news to see this important meeting is being “postponed”! But this only fortifies my drive and passion for the important work we are doing in rare disease research. I hope to still meet with many colleagues in the area next week! I will not give up! 💪 https://lnkd.in/gmURZCqa
-
Vanguard Clinical's CEO, Tiffany Sepp, and Business Development Partner, John Hixon, are looking forward to connecting with you at Nevada Psychiatric Association 30th Annual National Psychopharmacology Update™!
-
-
Don't miss a chance to connect with our CEO Tiffany Sepp and our Business Development Partner John Hixon at SCOPE in February!
-